NCT07707765 The Effect of Early Intervention on the Incidence of Posttraumatic Stress Disorder After Intensive Care Hospitalization Due to Sepsis
| NCT ID | NCT07707765 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barzilai Medical Center |
| Condition | PTSD - Post Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-07-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In recent years, the survival rate among intensive care patients has improved due to advancements in diagnosing severe infections and the use of broad-spectrum antibiotics. However, many survivors face long-term complications, known as Post-Intensive Care Syndrome (PICS), including physical, cognitive, and psychological impairments such as post-traumatic stress disorder (PTSD), anxiety, and depression. Approximately 9-27% of ICU survivors develop these symptoms, particularly those hospitalized due to sepsis. Common risk factors include traumatic hospital experiences, delirium, and extended mechanical ventilation. Despite the prevalence of these issues, most medical centers lack structured models for screening and early intervention, highlighting the need for evaluations of early intervention strategies to support at-risk patients post-discharge and improve their quality of life.
Eligibility Criteria
Inclusion Criteria: * Discharged from ICU due to sepsis * Age over 18 years old Exclusion Criteria: * Age under 18 years old * Lack of consent * Dementia/ mental retardation or any other condition due to which the patient cannot fill the questionnaires or participate in the psychiatric interview. * A cute psychosis or other psychiatric condition nesiccating psychiatric treatment.
Contact & Investigator
daniel Leshin Carmel, MD
PRINCIPAL INVESTIGATOR
Barzilai Medical Center
Frequently Asked Questions
Who can join the NCT07707765 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying PTSD - Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07707765 currently recruiting?
Yes, NCT07707765 is actively recruiting participants. Contact the research team at danielles@bmc.gov.il for enrollment information.
Where is the NCT07707765 trial being conducted?
This trial is being conducted at Ashkelon, Israel.
Who is sponsoring the NCT07707765 clinical trial?
NCT07707765 is sponsored by Barzilai Medical Center. The principal investigator is daniel Leshin Carmel, MD at Barzilai Medical Center. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.